Imaging Study to Investigate Safety and Diagnostic Performance of rhPSMA 7.3 (18F) PET Ligand in Suspected Prostate Cancer Recurrence (SPOTLIGHT) Read more about Imaging Study to Investigate Safety and Diagnostic Performance of rhPSMA 7.3 (18F) PET Ligand in Suspected Prostate Cancer Recurrence (SPOTLIGHT)
Randomized Trial in Adult Subjects With Acute Migraines Read more about Randomized Trial in Adult Subjects With Acute Migraines
Study of Pembrolizumab With Concurrent Chemoradiation Therapy Followed by Pembrolizumab With or Without Olaparib in Stage III Non-Small Cell Lung Cancer (NSCLC) (MK-7339-012/KEYLYNK-012) Read more about Study of Pembrolizumab With Concurrent Chemoradiation Therapy Followed by Pembrolizumab With or Without Olaparib in Stage III Non-Small Cell Lung Cancer (NSCLC) (MK-7339-012/KEYLYNK-012)
A Study to Evaluate Ketamine for the Treatment of Rett Syndrome Read more about A Study to Evaluate Ketamine for the Treatment of Rett Syndrome
Long-term Safety Study of BHV-3500 (Zavegepant*) for the Acute Treatment of Migraine Read more about Long-term Safety Study of BHV-3500 (Zavegepant*) for the Acute Treatment of Migraine
A Multicenter Expanded Access Treatment Protocol of Lurbinectedin in Previously Treated SCLC in the USA Read more about A Multicenter Expanded Access Treatment Protocol of Lurbinectedin in Previously Treated SCLC in the USA
Apixaban for the Acute Treatment of Venous Thromboembolism in Children Read more about Apixaban for the Acute Treatment of Venous Thromboembolism in Children
Patient Specific Optimized Therapy Post-Market Clinical Follow-up Study Read more about Patient Specific Optimized Therapy Post-Market Clinical Follow-up Study
Evaluation of S-600918 in Adults With Refractory Chronic Cough Read more about Evaluation of S-600918 in Adults With Refractory Chronic Cough
A Study Comparing the Efficacy and Safety of Nivolumab in Combination With Bacillus Calmette-Guerin (BCG) Versus BCG Alone in Participants With High-Risk Non-Muscle Invasive Bladder Cancer (HR NMIBC) Read more about A Study Comparing the Efficacy and Safety of Nivolumab in Combination With Bacillus Calmette-Guerin (BCG) Versus BCG Alone in Participants With High-Risk Non-Muscle Invasive Bladder Cancer (HR NMIBC)